This study is looking at different breathing treatments to help your lungs recover after heart surgery. It compares three types of respiratory therapies: EzPAP, Metaneb, and Intermittent Positive Pressure Breathing (IPPB). These therapies help expand your lungs and prevent problems like lung collapse after surgery. Researchers want to see which therapy works best to improve your lung function, specifically how much air you can breathe out forcefully (FEV1/FVC). You might be able to join if you are between 18 and 80 years old, had certain heart surgeries through a chest incision, and are admitted to the Cardiovascular ICU. The study aims to enroll 324 participants.

Study design

This is an interventional study where participants are randomly assigned to one of three respiratory therapies. It plans to enroll 324 participants.

What's involved

You would receive 10 minutes of your assigned respiratory therapy four times daily. This would continue for up to 96 hours post-surgery or until discharge from the ICU.

Compensation

Not stated in the trial record.

Follow-up

Your lung function will be assessed for up to 96 hours after surgery or until you are discharged from the intensive care unit (ICU), whichever comes first.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.